The global coronavirus disease (COVID-19) pandemic, since early 2020, has severely affected not only the emergency medical system in Japan (1), but also patient care at the outpatient clinics. To reduce the risk of COVID-19 infection, people were requested to refrain from unnecessary and nonurgent outings or from visiting crowded places, with a call to "avoid the three Cs" (closed spaces, crowded places, and close-contact settings) (2) based on the Act on Special Measures for Pandemic Influenza and New Infectious Diseases Preparedness and Response (https://elaws.e-gov.go.jp/document?lawid=4 24AC0000000031). People also refrained from visiting outpatient clinics (3), leading to a significant decrease in the number of ambulatory visits to internal medicine outpatient clinics in Japan by more than 10% in April-May 2020 compared to April-May 2019 (4). In addition, the ban on subsequent visits by telephone (or telephone re-examination) at outpatient clinics as an alternative to ambulatory care for chronic diseases was removed by the Ministry of Health, Labor and Welfare (MHLW) since March 2020 as an exceptional measure against the COVID-19 pandemic (5): in terms of reimbursement, it became newly available to claim a "subsequent visit fee" along with the "prescription fee", even in case of telephone visits.What is concerned in these measures against COVID-19 pandemic is that they are not always feasible for some patients with chronic neurological diseases (e.g., dementia, epilepsy, or Parkinson's disease), who are one of those considered as vulnerable to COVID-19 infection due to their old age or comorbid status (6). Since patients with chronic neurological diseases need